Molecular mechanistic associations of human diseases

Philip Stegmaier1, Mathias Krull, Nico Voss

  • 1BIOBASE GmbH, Halchtersche Strasse 33, D-38304 Wolfenbüttel, Germany. philip.stegmaier@biobase-international.com

BMC Systems Biology
|September 7, 2010
PubMed

Insights

This study introduces a statistical method to identify human disease associations and predict disease genes. The approach successfully clustered diseases and identified potential therapeutic targets, advancing biomedical research.

Area of Science:

  • Biomedical research
  • Genetics
  • Computational biology

Background:

  • Understanding human disease relationships offers new avenues for biomedical research.
  • Advances in human genetics highlight the need for methods to identify disease associations and predict disease genes.

Purpose of the Study:

  • To develop a statistical approach for inferring meaningful associations between human morbidities.
  • To utilize inferred disease associations for the prediction of disease genes.
  • To gain insights into the network of human diseases.

Main Methods:

  • Utilized approximately 10,000 manually collected causal disease/gene associations.
  • Developed a statistical method to infer disease associations.
  • Analyzed biological functions to characterize disease clusters.

Main Results:

  • Successfully clustered cardiometabolic, endocrine, immune, neoplastic, and neurodegenerative disorders.
  • Confirmed characteristic biological functions within disease clusters.
  • Inferred disease relationships align with known clinical associations and comorbidities.
  • Identified potential disease genes relevant to therapeutic target research.

Conclusions:

  • Causal molecular mechanisms provide a unified framework for disease classification, association analysis, and gene prediction.
  • The method's applicability extends beyond genetic diseases to chronic illnesses with environmental or sequential pathology.
  • Results are valuable for understanding complex diseases and identifying therapeutic targets.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...